Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (262)

« Back to Publications

Structures of proteinase 3 and the CD177 receptor complex reveal a major autoantibody epitope.

Zheng-Gérard C. et al, (2026), EMBO Rep

B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings.

Bundi CK. et al, (2026), Front Immunol, 17

Structural basis for synergistic antibody protection against the essential malaria invasion complex protein RIPR

Williams BG. et al, (2025)

Synergistic non-neutralizing plasma antibodies to PfRH5 drive potent malaria parasite growth inhibition

Marchioni J. et al, (2025)

Structural basis for synergistic antibody protection against the essential malaria invasion complex protein RIPR

Williams BG. et al, (2025)

B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings

Bundi CK. et al, (2025)

Harnessing Prophylactic Vaccines for Targeted Cancer Immunotherapy by Phage-Guided Delivery of Cognate Antigens to Tumors.

Hajitou A. et al, (2025)

Evaluating the potential of cross-species neutralization of anti-PfCyRPA and anti-PfRIPR Monoclonal Antibodies.

Guerra N. et al, (2025)

Addition of blood stage monoclonal antibody improves protection afforded by anti-sporozoite antibody alone in a humanized mouse model of Plasmodium falciparum malaria

Kirtley P. et al, (2025)

Diagnosis of Plasmodium falciparum malaria at very low parasitaemias using a commercially available LAMP assay and RDT.

Payne RO. et al, (2025), Trans R Soc Trop Med Hyg, 119, 1149 - 1156

Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.

Hou MM. et al, (2025), Nat Commun, 16

Plasmodium falciparum infection induces T cell tolerance that is associated with decreased disease severity upon re-infection.

Muñoz Sandoval D. et al, (2025), J Exp Med, 222

Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children.

Natama HM. et al, (2025), Lancet Infect Dis, 25, 495 - 506

An experimental model of clinical immunity for human malaria

Hou MM. et al, (2025)

Using P. knowlesi to unravel DBP biology and facilitate scalable assessment of PvDBP polymorphisms in parasite fitness and antibody susceptibility

Kousis K. et al, (2025), MALARIA JOURNAL, 24

Load More

1
2
3
4
5
6
7
...
»